February 2021 cover of Diabetes and Metabolism

JF. Gautier publishes in Diabetes & Metabolism

Impact of BMI on prevalence of coronary atherosclerotic lesions in non-smoking premenopausal diabetic women: A monocentric study

Laurence Salle, Margot Denis, Florine Feron, Jean-Guillaume Dillinger, Patrick Henry, Jean-François Gautier, Jean-Philippe Kevorkian

Women free of diabetes mellitus (DM) are less likely to develop atherosclerosis than men. In contrast, In women with DM, this difference is less obvious, given a phenomenon referred to as ‘the female disadvantage’. 

To assess the prevalence of coronary artery disease (CAD) in premenopausal, non-smoking women with either type 1 or 2 DM, authors conducted a single-centre, observational, retrospective study at Lariboisière Hospital in Paris, France, that included people who had undergone 16,889 coronary angiographies (CAs) between April 2009 and December 2019.

The 101 patients included in the study were 42 women (41.6%) and 59 men (58.4%).

Significant CAD was found in 40% (17/42) of women and 66% (39/59) of men, although CAD topography and severity did not differ significantly between the two groups. In addition, in patients with CAD, the proportion of patients with type 2 DM, those requiring insulin, mean age, average duration of DM and usual CV risk factors (high blood pressure, dyslipidemia, familial CV disease) were similar between the two groups. Moreover, the men and women with CAD had comparable microangiopathic complications. However, BMI was significantly higher in women with CAD vs men with CAD whereas, in the subgroup of patients without CAD, BMI did not differ significantly between women (n = 25) and men.

Overall, in a selected population of those undergoing CA, the prevalence of CAD in young, premenopausal, non-smoking women with DM and cardiac symptoms was high (40%), and the impact of obesity on the risk of CAD appears to be greater in women than in men. Given the large amount of available data, gender-specific factors are thought to explain the higher CV risk in women. Thus, personalized screening for women is mandatory. 

To read the full paper, head to the following link: